Parkinson DiseaseNCT07390825
Evaluation of the Effects of Aquatic Therapy on Activities of Daily Living, Walking, Balance, Posture, Pain, and Depression in Parkinson's Patients
A study testing Aquatherapy and home exercise in people with Parkinson Disease, run by Ankara City Hospital Bilkent at 2 sites in Turkey (Türkiye).
Trial summary
Parkinson's Disease (PD) is a progressive neurodegenerative disorder characterized by motor symptoms such as bradykinesia, tremors, and postural instability, as well as various non-motor symptoms. Read more about this study
- Who is it for?
- Ages 40 to 80 years
- Conditions the study is for
- Parkinson Disease
- What is being tested?
- Aquatherapy and home exercise
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 42 participants
- Where
- 2 sitesTurkey (Türkiye)
- Study dates
- 1 Jan 2025to 1 Aug 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Having a diagnosis of Idiopathic Parkinson's Disease between the ages of 40-80 and consenting to the treatment.
- Being regularly followed by a neurologist and having a stable medical treatment regimen for at least 3 months.
- Having a disease stage between 1-3 according to the Modified Hoehn-Yahr Staging Scale (MHY).
- A score of 24 or higher on the Mini-Mental State Examination (MMSE).
- Being able to verticalize independently and ambulate with or without assistance.
Who cannot join
- Having orthopedic, rheumatological, or non-Parkinson's neurological disorders that affect functional status.
- Having a medical treatment regimen that has been modified within the last 3 months.
- Presence of Atypical Parkinson's Disease.
- Visual impairment.
- Presence of dementia.
- Decompensated cardiac or respiratory failure.
Show all 13Show fewer
- Diabetes insipidus.
- Presence of systemic infection.
- Impaired skin integrity or the presence of skin infections.
- Increased sensitivity to inhaled steam or water chemicals.
- History of epilepsy or asthma.
- Urinary or fecal incontinence.
- Refusal to participate in or consent to the treatment.
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)2 sites, 2 recruiting
- Recruiting
Bilkent City Hospital
Ankara, ÇANKAYA, 06800
- Recruiting
Bilkent City Hospital
Çankaya, Ankara, 06800
Duygu Yanıktaş, MD, 05059025460 ext. 90, yanktasduygu@gmail.com
Duygu Yanıktaş, MD
About this study
Parkinson's Disease (PD) is a progressive neurodegenerative disorder characterized by motor symptoms such as bradykinesia, tremors, and postural instability, as well as various non-motor symptoms. Conventional land-based rehabilitation is standard; however, aquatherapy-utilizing water's buoyancy, hydrostatic pressure, and viscosity-offers a promising alternative to improve balance and mobility while reducing fall risks. This study aims to evaluate the effects of aquatherapy on gait, balance, posture, freezing of gait, activities of daily living (ADL), pain, and depression in Turkish PD patients.
This is a prospective, single-blind, randomized controlled trial involving 42 patients at Ankara City Hospital. Participants will be divided into two groups:
Read more
- Group 1 (Control): Home-based exercise program (5 days/week for 6 weeks).
- Group 2 (Intervention): Home-based exercises plus supervised aquatherapy (3 sessions/week, 45 minutes each, in a 30-32°C pool).
The study utilizes high-tech objective measurements and validated scales:
- Gait \& Posture: Zebris Gait Analysis (spatiotemporal parameters) and Diers Formetric 4D (topographical posture analysis).
- Balance: HUR-Smart Balance device and the Berg Balance Scale.
- Clinical Scales: PDQ-39 (quality of life), Freezing of Gait Questionnaire, Falls Efficacy Scale, MMSE (cognitive), Beck Depression Inventory, and VAS (pain).
This research is noteworthy as the first aquatherapy study among Turkish PD patients to utilize a large sample size and standardized aquatic exercise protocols. It seeks to provide a comprehensive analysis of both motor and non-motor improvements, potentially establishing aquatherapy as a superior adjunctive treatment for enhancing functional independence in Parkinson's patients.
Primary hypothesis or outcome measure : Parkinson's Disease Questionnaire-39 . PDQ-39 is a patient-reported outcome measure designed to evaluate the health-related quality of life in Parkinson's patients across eight specific domains, including mobility, activities of daily living, and emotional well-being.
Read the detailed description
Abstract / Project Description Parkinson's Disease (PD) is a progressive neurodegenerative disorder characterized by the degeneration of dopamine-producing cells in the substantia nigra, ranking as the second most common neurodegenerative disease after Alzheimer's. The prevalence of the disease in Turkey is approximately 2/1000. The primary symptoms of Parkinson's disease include bradykinesia, resting tremor, rigidity, and postural instability. Posture, balance, and gait disturbances are significant findings that emerge during the course of the disease, causing severe disability. The gait pattern in PD varies across different stages and affects patients to varying degrees. Typically, a shortening of step length, patients walk slowly with small steps. In advanced stages, difficulty in initiating gait, freezing of gait, and postural instability are frequently developing symptoms. In addition to classic motor findings, non-motor symptoms such as urinary incontinence, sexual dysfunction, orthostatic hypotension, sleep disorders, depression, anxiety, and pain may also be observed.
The Modified Hoehn \& Yahr Staging is a scale used to stage Parkinson's disease, with proven validity and reliability in Turkish. Developed by Hoehn and Yahr in 1967, this system allows both the patient and the clinician to easily define the severity of the disease and evaluate its progression across five stages. In the literature, Stages 1 and 2 are classified as "mild," Stage 3 as "moderate," and Stages 4 and 5 as "severe".
As conventional rehabilitation therapy, Parkinson's patients are frequently prescribed land-based gait and mobilization, posture, relaxation exercises, occupational therapy, and respiratory and swallowing exercises. Whether combined with other therapies or not, aquatherapy improves balance and functional mobility in PD patients compared to conventional rehabilitation. Aquatherapy, developed to improve balance, make walking more functional, and minimize strength imbalances between muscles, is considered a viable method for PD .
Aquatherapy is a rehabilitation method based on exercises performed in water using the physical properties of water . It is beneficial in the treatment of musculoskeletal, neurological, and cardiopulmonary diseases, among other conditions. The therapeutic safety margin of aquatherapy is quite broad . During treatment, the physical properties of water are utilized: hydrostatic pressure increases lymphatic and venous return in the extremities, contributing to the reduction of edema. Due to the buoyancy of water, patients move more comfortably; body weight is reduced by 90% with immersion up to the cervical region and by 60% up to the xiphoid process . Because of water's viscosity, resistance to movement is higher than in air, allowing movements to be performed at a constant speed. This resistance makes water an effective environment for strengthening. Additionally, heat can be retained or transferred through the thermodynamic effect of water . Aquatherapy is recognized as an effective adjunctive treatment in PD, particularly for improving motor symptoms . It reduces pressure on the joints, alleviates pain, provides support during movement, and reduces the risk of falling, thereby helping patients improve their balance skills .
In this study, the aquatherapy exercise program will be conducted in a therapy pool with a depth of 120 cm. Patients will be recommended to wear aquatic shoes to prevent slipping. Access to the pool will be provided via a lift. The water temperature will be maintained at 30-32°C. The aim of this study is to investigate the effects of aquatherapy on gait, balance, posture, freezing, activities of daily living (ADL), pain, and depression in Parkinson's patients.
- Expected Benefits and Risks of the Research In this study investigating the efficacy of aquatherapy in PD, patients will be divided into two groups: the first group will receive only home-based exercises, while the second group will receive aquatherapy for 45 minutes three days a week in addition to the home exercise program. The objective is to evaluate the efficacy of aquatherapy on ADLs, gait, balance, posture, pain, and depression.
Expected contributions to the literature include:
- Being the first aquatherapy study conducted among Turkish patients diagnosed with Parkinson's.
- Evaluating balance, gait, posture, depression, and pain within the same study.
- Utilizing a larger sample size compared to existing studies in the literature.
- Standardizing aquatherapy exercises for Parkinson's patients. Potential risks include patient non-compliance with the treatment, sensitivity to pool chemicals, and the development of exercise intolerance.
- Type, Scope, and Design of the Planned Research This study is designed as a prospective, single-blind, randomized controlled trial. Patients diagnosed with Parkinson's who apply to the Ankara City Hospital Physical Medicine and Rehabilitation Hospital outpatient clinic and meet the inclusion criteria will be included. Informed consent will be obtained from participants. Clinical and demographic data will be recorded. The 42 patients included in the study will be divided into two groups using the single-blinded sealed envelope technique.
- Group 1: Will perform home exercises at least 5 days a week for 6 weeks.
- Group 2: Will perform the home exercise program 5 days a week, plus aquatherapy exercises 3 days a week for 6 weeks under the supervision of a physiotherapist.
Patients will be evaluated before and after treatment. Home exercises for Group 1 include posture, flexibility and stretching, balance-coordination, strengthening, and gait exercises. For Group 2, in addition to home exercises, a pool prescription including water walking, side-stepping, forward and lateral lunges, single-leg stance/balance, hip kicks at the pool wall, deep-water cycling, arm raises, and standing knee raises will be implemented.
The following scales, which have proven Turkish validity and reliability, will be utilized in the study: Parkinson's Disease Questionnaire-39 (PDQ-39), Berg Balance Scale, Freezing of Gait Questionnaire, Falls Efficacy Scale, Mini-Mental State Examination (MMSE), Beck Depression Inventory, and the Visual Analog Scale (VAS), MDS-Unified Parkinson's Disease Rating Scale .
- Gait Analysis: Patients' gait patterns will be evaluated using the Zebris gait analysis system. Parameters to be measured include step length (distance between two consecutive footprints), step time (duration to complete a gait cycle), step width (mediolateral distance between ankle joint centers), walking speed, and cadence.
- Posture Analysis: Postural assessments will be conducted using the Diers Formetric 4D system, allowing for a comprehensive topographical analysis of the spine and pelvis.
- Balance Testing: Balance assessments will be performed using the HUR-Smart Balance device to provide objective data on stability and weight distribution.
- Conditions
- Parkinson Disease
- Being tested
- Aquatherapy, home exercise
- Keywords
- Parkinson's Disease, Aquatherapy, Rehabilitation of Parkinson's Disease
- Medical subject headings
- Parkinson Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AquatherapyOther
The specific aquatic exercise protocol for Group 2, conducted in a 120 cm deep therapy pool at 30-32°C, includes the following exercises:
Gait and Mobility: Water walking (forward and backward) and side-stepping.
Dynamic Balance: Forward and lateral lunges, and single-leg stance/balance drills.
Lower Extremity Strengthening: Hip kicks performed at the pool wall (flexion, extension, and abduction) and standing knee raises.
Upper Body and Coordination: Arm raises (multi-directional) and deep-water cycling movements.
Home Exercise Component: In addition to aquatic sessions, patients will continue land-based exercises including posture correction, flexibility/stretching, balance-coordination training, and strengthening.
home exerciseOther
Group 1 patients will be prescribed a home exercise program at least 5 days per week for a duration of 6 weeks
| Study group | Role | What they receive |
|---|---|---|
| Arm 1: Control Group (Home-based Exercise) | Experimental | Control Group (Home-based Exercise) Receives: Other: home exercise |
| Arm2: Experimental Group | Experimental | Experimental Group (Aquatherapy + Home-based Exercise) Receives: Other: Aquatherapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Parkinson's Disease Questionnaire-39
Patients' quality of life will be evaluated using the Parkinson's Disease Questionnaire-39 (PDQ-39).The PDQ-39 is a 39-item questionnaire that covers eight distinct dimensions of functioning and well-being. The domains include: Mobility , Activities of Daily Living, Emotional Well-being , Stigma, Social Support, Cognition, Communicatio, Bodily Discomfort.The questionnaire uses a 5-point Likert response format where patients rate their experiences from "never" (0) to "always" (4). For each of the eight dimensions, a score is calculated and normalized to a 0-100 scale using the formula:Dimension Score = (Sum of Item Scores / Maximum Possible Score for Dimension) × 100 each dimension the minimum possible score is 0 and the maximum possible score is 100 after normalization. Considering the entire PDQ-39, the raw total score ranges from 0 to 156, where 0 represents the best possible quality of life and 156 the worst possible quality of life.
Measured: From enrollment to the end of treatment at 6 weeks
Secondary outcomes (1)
Berg Balance Scale
The Berg Balance Scale will be utilized to measure the patients' balance; the minimum possible total score on the Berg Balance Scale is 0, and the maximum possible score is 56. Higher scores indicate better balance performance, with 0 reflecting severe balance impairment and 56 representing normal balance function.
Measured: From enrollment to the end of treatment at 6 weeks.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Feb 2026
- Study start1 Jan 2025
- Primary completion1 Aug 2026 (estimated)
- Study completion1 Aug 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Parkinson DiseaseStudies of the same condition, open and under way.
- More trials run by Ankara City Hospital BilkentThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 42 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Ankara City Hospital Bilkent
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Duygu Yanıktaş, Ankara City Hospital Bilkent
- Investigators
- Halil Uçan, Prof. Doctor, Study director, Bilkent City Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07390825
- Sponsor's protocol ID
- TABED 1-25-938
- Status last verified
- Feb 2026
- First submitted
- 23 Jan 2026
- Last updated
- 5 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be shared publicly to protect patient confidentiality and ensure strict adherence to personal data protection laws. The raw data contains sensitive health information that could potentially lead to the de-identification of participants, which would violate the ethical terms outlined in the informed consent forms
Publications
Pinto C, Salazar AP, Marchese RR, Stein C, Pagnussat AS. The Effects of Hydrotherapy on Balance, Functional Mobility, Motor Status, and Quality of Life in Patients with Parkinson Disease: A Systematic Review and Meta-analysis. PM R. 2019 Mar;11(3):278-291. doi: 10.1016/j.pmrj.2018.09.031.
PubMed 30884205
Study at a glance
From the registry record, last updated by the sponsor on 5 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of the Effects of Aquatic Therapy on Activities of Daily Living, Walking, Balance, Posture, Pain, and Depression in Parkinson's Patients
- ClinicalTrials.gov ID
- NCT07390825
- Acronym / sponsor ID
- TABED 1-25-938
- Conditions
- Parkinson Disease
- Keywords
- Parkinson's Disease, Aquatherapy, Rehabilitation of Parkinson's Disease
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 42 participants (estimated)
- Lead sponsor
- Ankara City Hospital BilkentUniversity, hospital or other
- Study start
- 1 Jan 2025 (actual)
- Primary completion
- 1 Aug 2026 (estimated)
- Study completion
- 1 Aug 2026 (estimated)
- First posted
- 5 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Parkinson's Disease (PD) is a progressive neurodegenerative disorder characterized by motor symptoms such as bradykinesia, tremors, and postural instability, as well as various non-motor symptoms. Conventional land-based rehabilitation is standard; however, aquatherapy-utilizing water's buoyancy, hydrostatic pressure, and viscosity-offers a promising alternative to improve balance and mobility while reducing fall risks. This study aims to evaluate the effects of aquatherapy on gait, balance, posture, freezing of gait, activities of daily living (ADL), pain, and depression in Turkish PD patients.
This is a prospective, single-blind, randomized controlled trial involving 42 patients at Ankara City Hospital. Participants will be divided into two groups:
- Group 1 (Control): Home-based exercise program (5 days/week for 6 weeks).
- Group 2 (Intervention): Home-based exercises plus supervised aquatherapy (3 sessions/week, 45 minutes each, in a 30-32°C pool).
The study utilizes high-tech objective measurements and validated scales:
- Gait \& Posture: Zebris Gait Analysis (spatiotemporal parameters) and Diers Formetric 4D (topographical posture analysis).
- Balance: HUR-Smart Balance device and the Berg Balance Scale.
- Clinical Scales: PDQ-39 (quality of life), Freezing of Gait Questionnaire, Falls Efficacy Scale, MMSE (cognitive), Beck Depression Inventory, and VAS (pain).
This research is noteworthy as the first aquatherapy study among Turkish PD patients to utilize a large sample size and standardized aquatic exercise protocols. It seeks to provide a comprehensive analysis of both motor and non-motor improvements, potentially establishing aquatherapy as a superior adjunctive treatment for enhancing functional independence in Parkinson's patients.
Primary hypothesis or outcome measure : Parkinson's Disease Questionnaire-39 . PDQ-39 is a patient-reported outcome measure designed to evaluate the health-related quality of life in Parkinson's patients across eight specific domains, including mobility, activities of daily living, and emotional well-being.
Detailed description
Abstract / Project Description Parkinson's Disease (PD) is a progressive neurodegenerative disorder characterized by the degeneration of dopamine-producing cells in the substantia nigra, ranking as the second most common neurodegenerative disease after Alzheimer's. The prevalence of the disease in Turkey is approximately 2/1000. The primary symptoms of Parkinson's disease include bradykinesia, resting tremor, rigidity, and postural instability. Posture, balance, and gait disturbances are significant findings that emerge during the course of the disease, causing severe disability. The gait pattern in PD varies across different stages and affects patients to varying degrees. Typically, a shortening of step length, patients walk slowly with small steps. In advanced stages, difficulty in initiating gait, freezing of gait, and postural instability are frequently developing symptoms. In addition to classic motor findings, non-motor symptoms such as urinary incontinence, sexual dysfunction, orthostatic hypotension, sleep disorders, depression, anxiety, and pain may also be observed.
The Modified Hoehn \& Yahr Staging is a scale used to stage Parkinson's disease, with proven validity and reliability in Turkish. Developed by Hoehn and Yahr in 1967, this system allows both the patient and the clinician to easily define the severity of the disease and evaluate its progression across five stages. In the literature, Stages 1 and 2 are classified as "mild," Stage 3 as "moderate," and Stages 4 and 5 as "severe".
As conventional rehabilitation therapy, Parkinson's patients are frequently prescribed land-based gait and mobilization, posture, relaxation exercises, occupational therapy, and respiratory and swallowing exercises. Whether combined with other therapies or not, aquatherapy improves balance and functional mobility in PD patients compared to conventional rehabilitation. Aquatherapy, developed to improve balance, make walking more functional, and minimize strength imbalances between muscles, is considered a viable method for PD .
Aquatherapy is a rehabilitation method based on exercises performed in water using the physical properties of water . It is beneficial in the treatment of musculoskeletal, neurological, and cardiopulmonary diseases, among other conditions. The therapeutic safety margin of aquatherapy is quite broad . During treatment, the physical properties of water are utilized: hydrostatic pressure increases lymphatic and venous return in the extremities, contributing to the reduction of edema. Due to the buoyancy of water, patients move more comfortably; body weight is reduced by 90% with immersion up to the cervical region and by 60% up to the xiphoid process . Because of water's viscosity, resistance to movement is higher than in air, allowing movements to be performed at a constant speed. This resistance makes water an effective environment for strengthening. Additionally, heat can be retained or transferred through the thermodynamic effect of water . Aquatherapy is recognized as an effective adjunctive treatment in PD, particularly for improving motor symptoms . It reduces pressure on the joints, alleviates pain, provides support during movement, and reduces the risk of falling, thereby helping patients improve their balance skills .
In this study, the aquatherapy exercise program will be conducted in a therapy pool with a depth of 120 cm. Patients will be recommended to wear aquatic shoes to prevent slipping. Access to the pool will be provided via a lift. The water temperature will be maintained at 30-32°C. The aim of this study is to investigate the effects of aquatherapy on gait, balance, posture, freezing, activities of daily living (ADL), pain, and depression in Parkinson's patients.
- Expected Benefits and Risks of the Research In this study investigating the efficacy of aquatherapy in PD, patients will be divided into two groups: the first group will receive only home-based exercises, while the second group will receive aquatherapy for 45 minutes three days a week in addition to the home exercise program. The objective is to evaluate the efficacy of aquatherapy on ADLs, gait, balance, posture, pain, and depression.
Expected contributions to the literature include:
- Being the first aquatherapy study conducted among Turkish patients diagnosed with Parkinson's.
- Evaluating balance, gait, posture, depression, and pain within the same study.
- Utilizing a larger sample size compared to existing studies in the literature.
- Standardizing aquatherapy exercises for Parkinson's patients. Potential risks include patient non-compliance with the treatment, sensitivity to pool chemicals, and the development of exercise intolerance.
- Type, Scope, and Design of the Planned Research This study is designed as a prospective, single-blind, randomized controlled trial. Patients diagnosed with Parkinson's who apply to the Ankara City Hospital Physical Medicine and Rehabilitation Hospital outpatient clinic and meet the inclusion criteria will be included. Informed consent will be obtained from participants. Clinical and demographic data will be recorded. The 42 patients included in the study will be divided into two groups using the single-blinded sealed envelope technique.
- Group 1: Will perform home exercises at least 5 days a week for 6 weeks.
- Group 2: Will perform the home exercise program 5 days a week, plus aquatherapy exercises 3 days a week for 6 weeks under the supervision of a physiotherapist.
Patients will be evaluated before and after treatment. Home exercises for Group 1 include posture, flexibility and stretching, balance-coordination, strengthening, and gait exercises. For Group 2, in addition to home exercises, a pool prescription including water walking, side-stepping, forward and lateral lunges, single-leg stance/balance, hip kicks at the pool wall, deep-water cycling, arm raises, and standing knee raises will be implemented.
The following scales, which have proven Turkish validity and reliability, will be utilized in the study: Parkinson's Disease Questionnaire-39 (PDQ-39), Berg Balance Scale, Freezing of Gait Questionnaire, Falls Efficacy Scale, Mini-Mental State Examination (MMSE), Beck Depression Inventory, and the Visual Analog Scale (VAS), MDS-Unified Parkinson's Disease Rating Scale .
- Gait Analysis: Patients' gait patterns will be evaluated using the Zebris gait analysis system. Parameters to be measured include step length (distance between two consecutive footprints), step time (duration to complete a gait cycle), step width (mediolateral distance between ankle joint centers), walking speed, and cadence.
- Posture Analysis: Postural assessments will be conducted using the Diers Formetric 4D system, allowing for a comprehensive topographical analysis of the spine and pelvis.
- Balance Testing: Balance assessments will be performed using the HUR-Smart Balance device to provide objective data on stability and weight distribution.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Arm 1: Control Group (Home-based Exercise) | Experimental | Other: home exerciseControl Group (Home-based Exercise) |
| Arm2: Experimental Group | Experimental | Other: AquatherapyExperimental Group (Aquatherapy + Home-based Exercise) |
Who may qualify
- Ages
- 40 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Having a diagnosis of Idiopathic Parkinson's Disease between the ages of 40-80 and consenting to the treatment.
- Being regularly followed by a neurologist and having a stable medical treatment regimen for at least 3 months.
- Having a disease stage between 1-3 according to the Modified Hoehn-Yahr Staging Scale (MHY).
- A score of 24 or higher on the Mini-Mental State Examination (MMSE).
- Being able to verticalize independently and ambulate with or without assistance.
Key exclusion criteria (13 listed)
- Having orthopedic, rheumatological, or non-Parkinson's neurological disorders that affect functional status.
- Having a medical treatment regimen that has been modified within the last 3 months.
- Presence of Atypical Parkinson's Disease.
- Visual impairment.
- Presence of dementia.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| AquatherapyThe specific aquatic exercise protocol for Group 2, conducted in a 120 cm deep therapy pool at 30-32°C, includes the following exercises: Gait and Mobility: Water walking (forward and backward) and side-stepping. Dynamic Balance: Forward and lateral lunges, and single-leg stance/balance drills. Lower Extremity Strengthening: Hip kicks performed at the pool wall (flexion, extension, and abduction) and standing knee raises. Upper Body and Coordination: Arm raises (multi-directional) and deep-water cycling movements. Home Exercise Component: In addition to aquatic sessions, patients will continue land-based exercises including posture correction, flexibility/stretching, balance-coordination training, and strengthening. | Other | Arm2: Experimental Group |
| home exerciseGroup 1 patients will be prescribed a home exercise program at least 5 days per week for a duration of 6 weeks | Other | Arm 1: Control Group (Home-based Exercise) |
Primary outcome
Parkinson's Disease Questionnaire-39
Time frame: From enrollment to the end of treatment at 6 weeks
Patients' quality of life will be evaluated using the Parkinson's Disease Questionnaire-39 (PDQ-39).The PDQ-39 is a 39-item questionnaire that covers eight distinct dimensions of functioning and well-being. The domains include: Mobility , Activities of Daily Living, Emotional Well-being , Stigma, Social Support, Cognition, Communicatio, Bodily Discomfort.The questionnaire uses a 5-point Likert response format where patients rate their experiences from "never" (0) to "always" (4). For each of the eight dimensions, a score is calculated and normalized to a 0-100 scale using the formula:Dimension Score = (Sum of Item Scores / Maximum Possible Score for Dimension) × 100 each dimension the minimum possible score is 0 and the maximum possible score is 100 after normalization. Considering the entire PDQ-39, the raw total score ranges from 0 to 156, where 0 represents the best possible quality of life and 156 the worst possible quality of life.
1 secondary outcome
Berg Balance Scale
Time frame: From enrollment to the end of treatment at 6 weeks.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Feb 2026.
- Background: PubMed 30884205Pinto C, Salazar AP, Marchese RR, Stein C, Pagnussat AS. The Effects of Hydrotherapy on Balance, Functional Mobility, Motor Status, and Quality of Life in Patients with Parkinson Disease: A Systematic Review and Meta-analysis. PM R. 2019 Mar;11(3):278-291. doi: 10.1016/j.pmrj.2018.09.031.
- Exercise program is based on clinical guidelines provided by ChoosePT.com, the official consumer information website of the American Physical Therapy Association (APTA).Link provided by the sponsor.
- Individual participant dataSharing planned: No. Individual participant data will not be shared publicly to protect patient confidentiality and ensure strict adherence to personal data protection laws. The raw data contains sensitive health information that could potentially lead to the de-identification of participants, which would violate the ethical terms outlined in the informed consent forms
Related trials for Parkinson Disease
Not yet recruitingPhase 1/2
STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic Carcinoma
NSCLC, Non-Small Cell Lung Cancer
Enrolling by invitationObservational study
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes
PARKINSON DISEASE (Disorder), Atypical Parkinsonism
RecruitingPhase 3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Cervical Cancer
Active, not recruitingPhase 1/2
Clinical Safety and Efficacy of Umbilical Cord Mesenchymal Stromal Cells-derived Exosomes in Patients With Parkinson's Disease
Parkinson Disease (PD)
Active, not recruitingObservational study
Adaptive DBS to Offset STN Dysregulation During Exercise in PD
Parkinson Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Halil Uçan, Prof. Doctor study director
Bilkent City Hospital
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Aquatherapy and home exercise in people with Parkinson Disease, run by Ankara City Hospital Bilkent at 2 sites in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 5 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Duygu Yanıktaş, MD (+905059025460, yanktasduygu@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Parkinson's Disease Questionnaire-39 (time frame: From enrollment to the end of treatment at 6 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07390825, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Feb 2026.